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Abstract
Background: Patients with back and neck pain are often seen in primary care and it is important to provide them
with tailored interventions based on risk stratification/triage. The STarT Back Screening Tool (SBT) is a widely used
screening questionnaire which has not yet been validated for a population with back and/or neck pain with short
duration. Our aim was to compare the concurrent validity of the SBT and the short form of the ÖMPSQ including
psychometric properties and clinical utility in a primary care setting.
Methods: Patients who applied for physiotherapy by direct access (January 2013 to January 2014) at 35 primary
care centers in south Sweden, with acute or subacute back and/or neck pain, aged 18–67 years, who were not
currently on sick leave or had been on sick leave less than 60 days were asked to complete the SBT and ÖMPSQ-
short questionnaire (n = 329). We used the Spearman’s rank correlations to study correlations, cross tabulation and
Cohen’s kappa to analyze agreement of patient classification. Clinical utility was described as clinician scoring
miscalculations and misclassifications of total and/or subscale scores.
Results: Completed SBT (9-items) and ÖMPSQ-short (10-items) data were available for 315/329 patients respectively.
The statistical correlation for SBT and ÖMPSQ-short total scores was moderately strong (0.62, p < 0.01). In subgroup
analyses, the correlations were 0.69 (p < 0.01) for males and 0.57 (p < 0.01) for females. The correlations were lower
among older age groups, especially females over 50 years (0.21, p = 0.11). Classification to high or low risk for long-
term pain and disability had moderate agreement (κ = 0.42). Observed classification agreement was 70.2%. The SBT
had fewer miscalculations (13/315) than the ÖMPSQ-short (54/315).
Conclusions: The correlation between the SBT and the ÖMPSQ-short scores were moderately strong for individuals
with acute or subacute back and/or neck pain. SBT seemed to be clinically feasible to use in clinical practice. We
therefore suggest that SBT can be used for individuals with both BP and/or NP in primary care settings but it is
important to be aware of that SBT’s agreement with the ÖMPSQ-short was poor among females aged over 50 years.
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Keywords: Back pain, Neck pain, Validity, Primary care, Psychological factors
* Correspondence: malin.forsbrand@ltblekinge.se
1Lund University, Faculty of Medicine, Department of Clinical Sciences Lund,
Orthopedics, Lund, Sweden
2Epidemiology and Register Centre South, Region Skåne, Lund, Sweden
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Forsbrand et al. BMC Musculoskeletal Disorders  (2017) 18:89 
DOI 10.1186/s12891-017-1449-9
Background
Musculoskeletal disorders are very common in the gen-
eral population worldwide [1–3] causing disability for
the individual and high costs for the society [4–6] The
Global Burden of Disease study reported in 2012 that
low back pain and neck pain (NP) was one of five top
ranked causes for years lived with disability [7] and in
European countries, individuals with back and NP con-
stitute a large proportion of health care seeking in pri-
mary care [8, 9]. Low back pain increases the risk of
general muscle pain, spinal pain and multiple health
complaints [10] and to have low back pain together with
neck-shoulder pain is associated with higher risk of
long-term sickness absence [11].
About 85% of all low back pain and NP is classified as
nonspecific, where the specific underlying disease or
pathology remains unknown [12]. Most individuals with
acute low back pain usually improve rapidly and return
to work within 1 month [13] but after 12 months, about
60% still experience relapses of pain [14]. In a Swedish
cohort of individuals seeking care for nonspecific low
back pain or NP about half of the population reported
pain and disability 5 years after onset [15].
Back pain (BP) is multi-factorial in both etiology and
management [16]. Treatments should therefore be tai-
lored based on the patient’s needs [17] and also equally
distributed in relation to the patient’s needs [18]. A wide
range of treatment options are available within primary
care [19, 20] but there is still insufficient knowledge on
how to direct individuals with BP to the right treatment
option at the right time [21, 22] and how to prevent
acute BP and NP from becoming chronic [23]. Conse-
quently, a clinical and research priority is to, at an early
stage, identify subgroups of patients with nonspecific BP
and NP who are at risk of developing long-standing dis-
ability, in order to optimize treatment [17, 24].
Psychological risk factors have a key role in the transi-
tion from acute to chronic pain and the development of
long-term disability [25–27]. The STarT Back Screening
Tool (SBT) [28] is a validated risk stratification tool that
includes questions on modifiable physical and psycho-
social risk factors for long-term BP, in order to match in-
dividuals to appropriate treatments according to their
prognostic profile. Patients are classified into three risk
groups; low, medium or high risk for long-term pain and
disability. Patients at low risk of poor outcome are di-
rected to supported self-management, education and ad-
vice including pain relief, encouragement to stay active
and are also informed about an overall good prognosis.
Those at medium risk are offered evidence-based
physiotherapy interventions such as manual therapy and
exercise. For those at high risk, a combined physical and
psychological approach is recommended [29]. Using the
SBT together with targeted treatments has shown
improved efficiency regarding patients’ clinical out-
comes and reduced health care costs in the United
Kingdom [30]. The SBT’s psychometric properties
have been tested in several countries and it is now
used in a number of different international settings
[31–35]. The SBT was recently cross-culturally
adapted and validated in Swedish in a small low back
pain population (n = 62) [36].
The Örebro Musculoskeletal Pain Screening Question-
naire (ÖMPSQ) aims to identify patients at risk for de-
veloping work disability due to BP and NP [37]. ÖMPSQ
is one of the most widely used screening questionnaires
and several studies demonstrate the utility of the
ÖMPSQ, both in research and clinical settings [38–41].
The ÖMPSQ was therefore considered the most appro-
priate reference standard against to validate the SBT. A
short form of the ÖMPSQ (ÖMPSQ-short) has been de-
veloped to further increase the clinical utility of the
ÖMPSQ [42]. The ÖMPSQ-short has earlier been
compared with the SBT for patients with low back pain
[33, 36, 43] but not yet for a population with patients
applying for physiotherapy treatment due to BP and/or
NP. The SBT has neither been compared or validated
against the ÖMPSQ-short nor for a large primary care
population in Sweden. Back and neck pain is common
symptom in the general population and the pain from
the back and neck often occurs concurrently [44].
Therefore clinicians need brief, practical tools for both
BP and NP to identify patients at risk of poor outcome
in order to decide the most appropriate interventions at
an early stage [28, 42]. Since there is a lack of short and
clinically useful instruments to guide clinicians in the
management of patients with non-specific BP and/or NP,
more research is needed. Therefore the overall aim of
this study was to study the concurrent validity of the
Swedish version of the SBT and the ÖMPSQ-short in a
population of patients with acute or subacute BP and/or
NP in a primary care setting. In addition, to investigate
the agreement regarding classification into risk groups
between the SBT and the ÖMPSQ-short and also to
describe clinical utility of the two instruments.
Methods
We conducted a cross-sectional study, nested within
an ongoing clinical trial including patients with acute
or subacute BP and/or NP (ClinicalTrials.gov ID:
NCT02609750).
Subjects
Patients were consecutively recruited between January
2013 and January 2014 from 35 primary care centers in
the southern parts of Sweden. We asked patients that
applied for physiotherapy due to an episode of acute or
subacute nonspecific BP and/or NP, to participate in the
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study. Patients that were between 18 and 67 years,
who were not currently on sick leave or had been on
sick leave less than 60 days, completed SBT and
ÖMPSQ-short at the first visit to the physiotherapist.
Patients that were pregnant, had severe pathology
(“red flags”) [19] or were not able to speak and
understand Swedish, were not included. Red flags
were screened for in a structured way [19] in connec-
tion to the clinical trial. If there were medical condi-
tions in urgent need for medical care or examination,
patients were referred to a doctor without delay. All
patients applied for physiotherapy services through
direct access. In all, 329 patients were identified.
Procedure
All participants completed the SBT and ÖMPSQ-short
at the same time at their first physiotherapy session. The
questionnaires were scored by the physiotherapist
according to the methods specified by the instrument
developers [28, 37]. Data from the SBT and the
ÖMPSQ-short questionnaires were manually entered
into a SPSS 22.0 database and were thoroughly checked
and validated. Patients were excluded if they had any
missing item on SBT [28] and for the ÖMPSQ-short,
missing items were handled as described by the original
ÖMPSQ [45], where one missing item was accepted.
The physiotherapist’s calculation of total score of SBT
and ÖMPSQ-short were independently checked and
errors corrected. All miscalculations were saved.
Instruments
The SBT is a 9-item questionnaire including questions
on known modifiable physical (item 1–4) and psycho-
social (item 5–9) risk factors for long-term disabling BP,
designed to support clinicians in directing individuals to
different levels of care [28]. Item 1–4 is about referred
leg pain, neck or shoulder pain, difficulties in walking
and difficulties in dressing. Item 5–9 form the psycho-
social subscale which screen for fear of physical activity,
anxiety, pain catastrophizing, depressive mood and over-
all impact from their BP. The SBT total scores range be-
tween 0 and 9. Items 1–8 have a dichotomous response
option; “disagree” (0p) or “agree” (1p). Item 9 uses a
5-point Likert Scale from “not at all” to “extremely”,
where responses “very much” or “extremely” are counted
as one point and the other responses as zero. A total
SBT score of ≤3 points indicates low risk, and patients
with a total score ≥4 points in combination with <4
points on the psychosocial subscale (item 5–9) are at
medium risk. A psychosocial subscale score of ≥4 points
indicates high risk for chronicity [28].
The ÖMPSQ-short is a 10-item questionnaire with
questions about psychosocial risk factors for work dis-
ability due to the pain [42]. The ÖMPSQ-short is based
on the original ÖMPSQ [37] and covers 2 items from
each of five concept areas: pain (item 1–2), self-
perceived function (item 3–4), distress (item 5–6), re-
turn to work expectancy (item 7–8) and fear avoidance
beliefs (item 9–10). Item number 1 (duration of pain)
has 10 categories, ranging from 0 to 1 week to more
than 52 weeks, scoring is from 1 to 10 points. Item
number 2–10 is rated from 0 to 10 point on a scale an-
chored by extremes, for example, “completely disagree”
to “completely agree” or “no pain” to “pain as bad as it
could be”. Item number 3, 4 and 8 has reversed scoring.
A total score is calculated (range 1–100) where 1 to 50
points indicate low risk and 51 to 100 points indicate
higher estimated risk for future work disability and
higher levels of pain [42].
Statistical analyses
SPSS 22.0 was used for all analyses. We used a non-
parametric approach which was chosen based on the
distribution of the data. We used the Spearman’s rank
correlation coefficient to study the correlations between
the SBT total scores with the ÖMPSQ-short total scores.
We also conducted subgroup analyses, based on pain
sites reported by the patients, gender and age. For pain
sites, we divided the population in two groups based on
the answer on question number two in SBT, which is
about neck or shoulder pain. All patients who reported
neck or shoulder pain were allocated to the NP + BP
group (a mixed group of patients with neck or shoulder
pain with or without BP). Patients who didn’t report
neck or shoulder pain were allocated to the BP group
and were regarded as having BP only. The reason for
not analyzing patients with neck pain only was that we
had no possibilities to identify them as we didn’t have
access to the diagnoses of the patients. For gender, we
divided the study population into females and males and
for age, we divided the population in three age groups
(≤39, 40–49 and ≥50 years). We found these age groups
clinically relevant to study as the age 40–49 years is a
period of life often associated with higher demands both
at home and at work and might therefore result in a
higher sick leave. A correlation coefficient less than 0.3
was considered as poor, 0.3–0.5 as fair, 0.6–0.8 moder-
ately strong and greater than 0.8 was considered very
strong [46].
We used cross-tabulation to describe the observed
agreement, regarding classification into risk groups, be-
tween the ÖMPSQ-short (low and high risk) and the
SBT (low, medium and high risk). To allow an agree-
ment analysis of the SBT and the ÖMPSQ-short risk
classifications, we did two analyses. First we merged the
low and medium risk group for the SBT in the first ana-
lysis and then we merged the medium and high risk
group for the SBT in a second analysis. We chose to
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present the results of the second analysis, in line with
Fuhro et al. [43] as this appeared to be the most clinic-
ally relevant solution [28]. The agreement between clas-
sifications to either high or low risk by the two
questionnaires was analyzed using Cohen’s kappa test
where <0.20 were considered as poor agreement, 0.21 to
0.40 fair agreement, 0.41 to 0.60 moderate agreement,
0.61 to 0.80 good agreement, and values over 0.80 very
good agreement [47]. The proportion of observed agree-
ment was calculated by percentage. The McNemar test
was used to determine if there were differences regard-
ing allocation to the “low” or “high” risk group by the
two instruments and to determine if the disagreement
observed was balanced or skewed towards the lower or
higher risk group.
We described the clinical utility of the two instru-
ments as screening tools from a clinician’s perspec-
tive. Clinical utility was described as clinician scoring
miscalculations and misclassifications of total and/or
subscale scores of the two instruments. First, we cal-
culated the number of physiotherapist scoring miscal-
culations of ÖMPSQ-short total scores and SBT total
and subscale scores. Then, we calculated the miscal-
culations that had led to a misclassification. To
analyze if a miscalculation of a total score had led to
a misclassification to a higher or lower risk group, we
used the cut-off scores specified by the instrument
developers [42, 48] with three risk groups in the SBT
(low, medium and high) and two risk groups of the
ÖMPSQ-short (low and high) [42].
Results
Study population
The flow chart of inclusion and exclusion of patients
through the study and reasons for exclusion is presented
in Fig. 1. There were 329 patients who consented to par-
ticipate in the study and all patients completed the SBT
and the ÖMPSQ-short questionnaires at the first physio-
therapy session. Three patients didn’t meet the inclusion
criteria of working age and were therefore not included
in the study. Eleven patients were excluded because of
missing items on the SBT questionnaires. In all, 315/329
patients (96%) were included in the final sample includ-
ing 197 females (62.5%) and 118 males (37.5%).
Baseline characteristics of the study population are
summarized in Table 1. In the BP population (n =
121) 51.2% were females and 48.8% were males. In
the NP + BP population (n = 194) 69.6% were females
and 30.4% were males. Among females (n = 197)
68.5% reported neck pain. Median age was 45 (range
20–66) for both females and males. The median
scores (range) for SBT and ÖMPSQ-short were 4
(0–9) and 46 (9–81) respectively (Table 1).
Correlations
The Spearman’s rank correlation coefficient for the
SBT total scores and the ÖMPSQ-short scores was
0.62 (p < 0.01) which was considered as moderately
strong (Fig. 2). The correlation between the SBT total
scores and the ÖMPSQ-short scores for patients with
BP (0.63, p < 0.01) and for patients with NP + BP
(0.60, p < 0.01) was also moderately strong.
A summary of the statistical correlations for subgroup
analyses, based on gender and age, is presented in
Table 2. In subgroup analyses we found that the correl-
ation for females was fair (0.57, p < 0.01) and for males it
was moderately strong (0.69, p < 0.01). For participants
aged ≤39 years, the correlation was moderately strong
(0.72, p < 0.01) and for the group between 40–49 years
(0.57, p < 0.01) and ≥50 years (0.50, p < 0.01), the correl-
ation was fair. In further subgroup analyses, when we
combined gender and age, we found the correlation for
males ≥50 years moderately strong (0.71, p < 0.01) and
for females ≥50 years poor (0.21, p = 0.11).
Observed agreement
The purpose of the SBT and ÖMPSQ-short was to iden-
tify patients that are at risk for long-term disability and
in need for extended treatment. The observed agreement
between the two questionnaires subgroup classification
is shown in Table 3. The SBT classified 53.7% as high
risk and 46.3% as low risk while the ÖMPSQ-short clas-
sified 36.5% as high risk and 63.5% as low risk (Table 3).
The proportion of total observed agreement between the
two questionnaires regarding participant classification to
low and high risk for long-term pain and disability was
70.2%. Thus, 29.8% was allocated in disagreement. Par-
ticipant classification by both questionnaires had moder-
ate agreement (κ = 0.42, p < 0.01). We found differences
regarding classification into low and high risk subgroups
(McNemar, p < 0.01). The disagreement observed (29.8%)
was significantly skewed towards the high risk group with
a higher proportion of patients allocated to the SBT high
risk group (53.7%) than to the ÖMPSQ-short high risk
group (36.5%).
Clinical utility
We studied the clinical utility from a clinician’s perspec-
tive. Physiotherapists had done more miscalculations on
total scores in the ÖMPSQ-short (54/315) than in the
SBT (13/315). In the SBT questionnaires we found 22
miscalculations of the SBT subscale scores. Among the
miscalculations of total scores, seven of the ÖMPSQ-
short questionnaires and five of the SBT questionnaires,
led to misclassifications to a higher or lower risk group.
In four respectively 21 SBT questionnaires, total scores
and subscale score calculations were missing. First
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author (MF) calculated these scores. There were no
missing calculations of total scores in the ÖMPSQ-short.
Discussion
This is the first time that the SBT has been compared
with the ÖMPSQ-short for a large group of patients
with acute or subacute BP and/or NP in primary care in
Sweden. This study demonstrated moderately strong
correlations between the SBT and ÖMPSQ-short total
scores for individuals with back and/or neck pain with
short duration. The observed classification agreement
was 70.2%. In subgroup analyses, we found the correl-
ation was lower among females than for males and also
lower among older age groups, especially females aged
over 50 years. Clinicians made less miscalculations with
the SBT compared to the ÖMPSQ-short.
The moderately strong correlation between SBT and
ÖMPSQ-short total scores (0.62) in this study is similar
to the results in a previous Swedish study (0.61) [36] and
a Brazilian study (0.73) [43] that also compared SBT and
ÖMPSQ-short total scores. Both these studies were in a
low back pain population. Higher correlations have been
reported when comparing the SBT with the original
ÖMPSQ (24 item) for patients with low back pain in an
English population (0.80) [49] and in a French popula-
tion (0.74) [31] but also lower correlations have been
Fig. 1 Flow chart of inclusion and exclusion of patients. 1Start Back Screening Tool. 2The Short Form of the Örebro Musculoskeletal Pain
Screening Questionnaire
Table 1 Characteristics of the study population, n = 315
Number Percent Median Range
Age
Total population 315 45 20–66
≤39 years 108 34.3
40–49 years 105 33.3
≥50 years 102 32.4
Gender
Female 197 62.5
Male 118 37.5
Pain sitea
BPb 121 38.4
NP + BPc 194 61.6
SBTd total score, 0–9 315 4 0–9
Low risk 146 46.3
Medium risk 133 42.2
High risk 36 11.4
ÖMPSQ-shorte total score, 0–100 315 46 9–81
Low risk 200 63.5
High risk 115 36.5
aPain site Based on question number 2 (Neck or shoulder pain) on SBT, bBP
Back pain, cNP + BP Patients with neck or shoulder pain (NP) with or without
back pain (BP), dSBT Start Back Screening Tool, eÖMPSQ-short Short form of the
Örebro Musculoskeletal Pain Screening Questionnaire
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found in a Finnish population (0.45) [33]. Cross-cultural
differences may be one factor that can explain the differ-
ences between different study results. In contrast to the
above mentioned studies, the study population in this
study also includes patients that can have NP, but this
does not seem to affect the correlations substantially.
In the subgroup analyses, we found the correlation
was lower in females than for males and was further re-
duced among increasing age groups. We have also used
other age groups in the analyses but regardless of which
type of age group we used, we found the same results.
We unexpectedly found the correlation for females
≥50 years as poor while the correlation for males
≥50 years were still moderately strong. We can’t rule out
that this difference between males and females ≥50 years
might be random but there may also be biological differ-
ences. There is a gender gap concerning low back pain,
where females are having more prevalent comorbidity of
neck and shoulder pain and psychosocial distress than
males [44]. In this study there were more females than
males and a greater share of females that had neck pain
(68.5 vs 50%). On the other hand, when studying differ-
ent age groups, a greater share of younger males had
neck pain (51.3%) compared to the oldest age group
(44.4%). This difference was not seen in females. In
other studies, comparing the SBT and the ÖMPSQ,
the percentage of females varies between 55.6 and
80.8% but no results on the percentage of participants
Fig. 2 Box plot graph of the ÖMPSQ-short scores against the SBT total scores, n = 315, r = 0.62. Asterisk (*) represents extreme values. One person
scored 9 points on SBT
Table 2 Spearman correlation coefficient between SBTa and ÖMPSQ-shortb total scores, n = 315
Population Males and Females Females Males
n r p n r p n r p
Total population 315 0.62 <0.01 197 0.57 <0.01 118 0.69 <0.01
BPc 121 0.63 <0.01 62 0.58 <0.01 59 0.62 <0.01
NP + BPd 194 0.60 <0.01 135 0.56 <0.01 59 0.68 <0.01
≤39 years 108 0.72 <0.01 69 0.73 <0.01 39 0.75 <0.01
40–49 years 105 0.57 <0.01 71 0.60 <0.01 34 0.50 <0.01
≥50 years 102 0.50 <0.01 57 0.21 0.11 45 0.72 <0.01
aSBT Start Back Screening Tool, bÖMPSQ-short Short form of the Örebro Musculoskeletal Pain Screening Questionnaire, cBP Back Pain, dNP + BP Patients with neck
or shoulder pain (NP) with or without back pain (BP)
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with neck pain, nor subgroup analyses for correlation
based on gender and age have been reported in these
studies [31, 33, 36, 43, 49].
Participant classification to low or high risk for long-
term pain and disability by the SBT and the ÖMPSQ-
short questionnaires had moderate agreement (κ = 0.42).
Similar results were also found in the Brazilian study (κ
= 0.49) [43] and in a study where they compared the
SBT with the original ÖMPSQ (24 item) in an English
population (κ = 0.57) [49]. The English study also
showed significant differences between the SBT and the
ÖMPSQ (24-item) regarding the threshold for high risk.
The proportion of patients allocated to the high risk
group in our study was higher for the SBT (53.7%) than
for the ÖMPSQ-short (36.5%) which also was found by
Fuhro et al. [43]. In contrast, Hill et al. [49] found that
the SBT allocated fewer (35%) patients to the high risk
group than the original ÖMPSQ (24-item) (38%). The
24-item ÖMPSQ has three risk groups, as the SBT. The
higher proportion of patients allocated to the high risk
group by the SBT in our study might have been influ-
enced of the high risk classification we used when we
merged the medium and high risk group for the SBT,
but this method was used both in our and in the
Brazilian study [43] but not in the UK-study [49]. Thus,
when clinicians use the SBT instead of the ÖMPSQ-short,
they will likely find more patients identified as medium or
high risk by the SBT compared to the ÖMPSQ-short.
When choosing a classification instrument, clinicians
and organizations need to be aware of, that patients at
medium and especially patients at high risk need a more
extensive treatment compared to those at low risk who
can be reassured and offered less intensive treatment
[29]. Patients at high risk are especially important to
identify at an early stage as this group of patients will
benefit most from psychological informed physiotherapy
approaches. But, it is also important to be aware of the
potential of misclassifying high risk and that there may
be patients not being high risk and not being appropriate
for the enhanced intervention approach.
However, patients with medium and high risk are
those who will benefit most from physiotherapy [30] and
to identify them at an early stage, will maximize treat-
ment benefit, reduce harm and increase health-care
efficiency by offering the right treatment to the right pa-
tient at the right time [17].
To the best of our knowledge, this is the first time that
clinical utility has been focused when comparing the two
instruments. It was a difference regarding completion
rates from patients with SBT having some incomplete
questionnaires (n = 11) while the ÖMPSQ-short had
none. One contributing factor might be the order in
which the questionnaires were completed. Patients com-
pleted the ÖMPSQ-short first, as the ÖMPSQ-short was
used as an inclusion criteria to the clinical trial (Clinical-
Trials.gov ID: NCT02609750). The physiotherapists
might have checked all questions and calculated the
ÖMPSQ-short scores more carefully. Physiotherapists in
Sweden are also more used to score the ÖMPSQ-short
than the SBT. The rates of missing calculations of total
and subscale scores in the SBT might be due to the in-
structions to the physiotherapists. They were not expli-
citly told to do these calculations. The fact that it was
the treating physiotherapist that administered and
scored the SBT and that they had different experiences
of using the two questionnaires may have influenced the
rates of miscalculations of scores. But, at the same time,
this might have had minimal impact of the results as
there were so many primary care centers (35) in differ-
ent regions included. The higher rate of miscalculations
of total scores in ÖMPSQ-short (54/315) compared to
SBT (13/315) indicates that the SBT is easier to score
for clinicians. A potential benefit of using the SBT in-
stead of the ÖMPSQ-short might be that the SBT seems
to be more clinical feasible to use in routine clinical
practice. More miscalculations in the ÖMPSQ-short
might be due to the more complex scoring with 0–10
points for each item and also the reversed scoring in three
items (3, 4 and 8). However, even though there were more
miscalculations of total scores in the ÖMPSQ-short than
in the SBT, there were no difference in misclassification to
either a higher or lower risk group between the ÖMPSQ-
short (n = 7) and the SBT (n = 5) questionnaires. Conse-
quently, miscalculations of the SBT and the ÖMPSQ-short
total scores do not seem to substantially influence the risk
classification. Clearly introducing electronic question-
naires with automatic summations have the potential to
eliminate errors even further.
Strengths and limitations
The main strength of the present study is the size of the
study population (n = 315) at a great number (35) of dif-
ferent real world primary care settings. The same indi-
viduals completed both the SBT and ÖMPSQ-short at
the same time. We have thoroughly checked and vali-
dated all questionnaires and also studied psychometric
properties and clinical utility in a primary care setting.
The population studied was relatively homogenous
Table 3 Observed agreement of SBTa (high risk =medium+ high
risk) and ÖMPSQ-shortb subgroups, n = 315
ÖMPSQ-short SBT
Low risk High risk Score
Low risk 126 74 200
High risk 20 95 115
Score 146 169 315
aSBT Start Back Screening Tool, bÖMPSQ-short Short form of the Örebro
Musculoskeletal Pain screening questionnaire
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including only patients with short duration of pain, not
participants with chronic pain. This means that we can
identify patients at risk of poor prognosis at an early
stage where it is still possible to do brief interventions
and influence outcome by treating modifiable prognostic
factors and stratify care.
To our knowledge, this is the first time SBT is vali-
dated in a population with both NP and BP. A limitation
in this study is that we have no diagnoses registered for
the study population and therefore we were not able to
distinguish patients diagnosed with only NP. On the
other hand, having NP with or without comorbid BP is
common [44, 50] and thus makes the results of this
study applicable to a common clinical situation. Another
limitation was that we merged the medium and high risk
group for the SBT in the analysis to allow a comparison
with the ÖMPSQ-short. But regardless of merging the
medium and high risk group or merging the low and
medium risk group for the SBT, we found significant dif-
ferences in observed agreement between the two instru-
ments. The observed classification agreement was 70.2%
but there was at the same time a disagreement rate of
29.8%. The agreement analysis strategy used in this
study by merging the medium and high risk group for
the SBT may limit the ability to evaluate for false posi-
tive or negative SBT medium risk classification. How-
ever, the findings in this study with a moderately strong
correlation between the SBT and the ÖMPSQ-short
scores support that the SBT can be used as a clinical tool
for patients with acute and subacute BP and/or NP in
primary care and that the SBT will provide clinicians
with more additional guidance in the level of care com-
pared to the ÖMPSQ-short. The SBT is designed for
stratified care, which involves targeting treatment to
subgroups of patients based on their key characteristics
[17] and we think this is an advantage in primary care
because clinical intuition does not always match consist-
ently to patient prognosis [51]. When using stratified
care, clinicians can minimize the risk of overtreat-
ment for low risk patients and give more appropriate
treatment for medium and high risk patients [30].
The SBT may help the physiotherapists, how to
prioritize between different treatments pathways. Fu-
ture studies are needed to study how the SBT can
predict chronic pain and work disability for the target
group of patients with BP and/or NP in primary care
and especially in the group of elderly females.
Conclusion
This study showed that the correlation between the
SBT and the ÖMPSQ-short scores were moderately
strong for individuals with acute or subacute BP and/
or NP. SBT seemed to be clinically feasible to use in
clinical practice.
We therefore suggest that SBT can be used for individ-
uals with both BP and/or NP in primary care settings
but it is important to be aware of that SBT’s agreement
with the ÖMPSQ-short was poor among females aged
over 50 years.
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